These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28650566)

  • 21. Bleeding pattern difference between levonorgestrel intrauterine system and copper intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women.
    Chen X; Li Q; Wang X; Chen J; Lv W; Shi B; Wang H; Luo J; Li J
    Curr Med Res Opin; 2018 May; 34(5):873-880. PubMed ID: 29298525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of a 52-mg levonorgestrel-releasing intrauterine system in women with cardiovascular disease.
    Ueda Y; Kamiya CA; Horiuchi C; Miyoshi T; Hazama R; Tsuritani M; Iwanaga N; Neki R; Ikeda T; Yoshimatsu J
    J Obstet Gynaecol Res; 2019 Feb; 45(2):382-388. PubMed ID: 30259601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case series on the use of levonorgestrel 52 mg intrauterine system after organ transplant.
    Juliato CRT; Stahlschmidt P; Fernandes A; Monteiro I; Bahamondes L
    Contraception; 2018 Sep; 98(3):252-254. PubMed ID: 29746814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A; Hussain M; Rishworth JR; Rees MC
    Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levonorgestrel-releasing intrauterine system (LNG-IUS 12) for prevention of pregnancy for up to five years.
    Nelson AL
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):833-842. PubMed ID: 28617060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and continued use of the levonorgestrel intrauterine system as compared with the copper intrauterine device among women living with HIV in South Africa: A randomized controlled trial.
    Todd CS; Jones HE; Langwenya N; Hoover DR; Chen PL; Petro G; Myer L
    PLoS Med; 2020 May; 17(5):e1003110. PubMed ID: 32442189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Romero SA; Young K; Hickey M; Su HI
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy during the use of levonorgestrel intrauterine system.
    Backman T; Rauramo I; Huhtala S; Koskenvuo M
    Am J Obstet Gynecol; 2004 Jan; 190(1):50-4. PubMed ID: 14749634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LNG-IUS 12: a 19.5 levonorgestrel-releasing intrauterine system for prevention of pregnancy for up to five years.
    Nelson AL
    Expert Opin Drug Deliv; 2017 Sep; 14(9):1131-1140. PubMed ID: 28696796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Application of levonorgestrel-releasing intrauterine system in early pregnancy: a case report].
    Gardyszewska A; Czajkowski K
    Ginekol Pol; 2012 Dec; 83(12):950-2. PubMed ID: 23488301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Chin J; Konje JC; Hickey M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas.
    Bahamondes MV; Hidalgo MM; Bahamondes L; Monteiro I
    Contraception; 2011 Nov; 84(5):e11-6. PubMed ID: 22018132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg versus other long-acting reversible contraceptives for contraception in Spain.
    Conde JCQ; Parra Ribes I; Perelló-Capo J; Lobo Abascal P; García IC; Andeyro García M; Gutiérrez Alés J; Herrero Conde M; Rius Tarruella J; Espinós Lafuente B
    Eur J Contracept Reprod Health Care; 2024 Oct; 29(5):224-232. PubMed ID: 38989683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial function in women using levonorgestrel-releasing intrauterine system (LNG-IUS).
    Selim MF; Hussein AF
    Contraception; 2013 Apr; 87(4):396-403. PubMed ID: 23332246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pain and bleeding pattern related to levonorgestrel intrauterine system (LNG-IUS) insertion.
    Van Schoubroeck D; Van den Bosch T; Ameye L; Veldman J; Hindryckx A; Werbrouck E; Timmerman D
    Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):154-6. PubMed ID: 24029596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age.
    Borgatta L; Buhling KJ; Rybowski S; Roth K; Rosen K
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):372-9. PubMed ID: 27494570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single, nulliparous Chinese females following surgical abortion.
    Li CF; Lee SS; Pun TC
    Contraception; 2004 Mar; 69(3):247-50. PubMed ID: 14969674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5 mg in contraception.
    Trussell J; Hassan F; Henry N; Pocoski J; Law A; Filonenko A
    Contraception; 2014 May; 89(5):451-9. PubMed ID: 24576791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-week postpartum intrauterine contraception insertion: a study of feasibility, patient acceptability and short-term outcomes.
    Zerden ML; Stuart GS; Charm S; Bryant A; Garrett J; Morse J
    Contraception; 2017 Jan; 95(1):65-70. PubMed ID: 27554014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.